BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19695075)

  • 1. Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes.
    Tsujimoto Y; Ishimura E; Tahara H; Kakiya R; Koyama H; Emoto M; Shoji T; Inaba M; Kishimoto H; Tabata T; Nishizawa Y
    Ther Apher Dial; 2009 Aug; 13(4):358-65. PubMed ID: 19695075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
    Ishimura E; Okuno S; Kono K; Fujino-Kato Y; Maeno Y; Kagitani S; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
    Diabetes Res Clin Pract; 2009 Mar; 83(3):320-6. PubMed ID: 19135755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
    Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
    Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study.
    Oomichi T; Emoto M; Tabata T; Morioka T; Tsujimoto Y; Tahara H; Shoji T; Nishizawa Y
    Diabetes Care; 2006 Jul; 29(7):1496-500. PubMed ID: 16801568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea.
    Park JI; Bae E; Kim YL; Kang SW; Yang CW; Kim NH; Lee JP; Kim DK; Joo KW; Kim YS; Lee H
    PLoS One; 2015; 10(8):e0136085. PubMed ID: 26285034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.
    Rhee JJ; Zheng Y; Montez-Rath ME; Chang TI; Winkelmayer WC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28592463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
    Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM
    Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control is a predictor of survival for diabetic patients on hemodialysis.
    Morioka T; Emoto M; Tabata T; Shoji T; Tahara H; Kishimoto H; Ishimura E; Nishizawa Y
    Diabetes Care; 2001 May; 24(5):909-13. PubMed ID: 11347753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients.
    Ok ES; Asci G; Toz H; Ritz E; Kircelli F; Sever MS; Ozkahya M; Sipahi S; Dheir H; Bozkurt D; Omer Z; Sahin OZ; Ertilav M; Ok E
    Clin Nephrol; 2014 Sep; 82(3):173-80. PubMed ID: 25079862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.
    Peng F; Xia X; He F; Li Z; Huang F; Yu X
    Perit Dial Int; 2015; 35(5):566-75. PubMed ID: 25395497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control and cardiovascular events in diabetic hemodialysis patients.
    Drechsler C; Krane V; Ritz E; März W; Wanner C
    Circulation; 2009 Dec; 120(24):2421-8. PubMed ID: 19948978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).
    Toida T; Sato Y; Nakagawa H; Komatsu H; Kikuchi M; Uezono S; Yamada K; Ishihara T; Hisanaga S; Kitamura K; Fujimoto S
    Nephrology (Carlton); 2016 Mar; 21(3):236-40. PubMed ID: 26272229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis.
    Inaba M; Maekawa K; Okuno S; Imanishi Y; Hayashino Y; Emoto M; Shoji T; Ishimura E; Yamakawa T; Nishizawa Y
    Clin Nephrol; 2012 Oct; 78(4):273-80. PubMed ID: 22541674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
    Li J; Ning NY; Rao QX; Chen R; Wang LJ; Lin ZQ
    BMC Cancer; 2017 Aug; 17(1):517. PubMed ID: 28774279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
    Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.